Hepatocellular carcinoma and hepatitis B virus
- PMID: 16673293
- DOI: 10.1055/s-2006-939753
Hepatocellular carcinoma and hepatitis B virus
Abstract
Chronic hepatitis B is the most common cause of hepatocellular carcinoma (HCC) in Asia. Integration of hepatitis B virus (HBV) genome is likely an early event of carcinogenesis. The integrated HBV genome may activate neighboring cellular genes directly to offer a selective growth advantage to the liver cells. Production of hepatitis B X protein can act as a transactivator on various cellular genes for tumor development. Hepatic inflammation and cirrhosis also favors the process of carcinogenesis. Various viral factors associated with hepatocellular carcinoma development include HBV genotype, basal core promoter mutations, and high viral load. Polymorphisms at the androgen receptor-regulating genes and cytokine genes are possible host factors associated with HCC. This review article summarizes the pathogenesis of HBV-related carcinogenesis and the viral and host factors that may increase the risk of HCC development.
Similar articles
-
Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.J Infect Dis. 2006 May 1;193(9):1258-65. doi: 10.1086/502978. Epub 2006 Apr 4. J Infect Dis. 2006. PMID: 16586363
-
Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.J Hepatol. 2008 Nov;49(5):718-25. doi: 10.1016/j.jhep.2008.06.026. Epub 2008 Jul 24. J Hepatol. 2008. PMID: 18801591
-
Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.Minerva Gastroenterol Dietol. 2006 Dec;52(4):387-406. Minerva Gastroenterol Dietol. 2006. PMID: 17108869 Review.
-
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.J Biomed Sci. 2008 Mar;15(2):137-45. doi: 10.1007/s11373-007-9225-8. Epub 2007 Dec 5. J Biomed Sci. 2008. PMID: 18058038 Review.
-
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.Gastroenterology. 2003 Feb;124(2):327-34. doi: 10.1053/gast.2003.50053. Gastroenterology. 2003. PMID: 12557138
Cited by
-
Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.Tumour Biol. 2013 Jun;34(3):1451-9. doi: 10.1007/s13277-013-0649-7. Epub 2013 Apr 6. Tumour Biol. 2013. PMID: 23564481
-
Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).Oncol Lett. 2015 Feb;9(2):527-534. doi: 10.3892/ol.2014.2727. Epub 2014 Nov 21. Oncol Lett. 2015. PMID: 25624883 Free PMC article.
-
Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis.Can J Gastroenterol Hepatol. 2016;2016:5234969. doi: 10.1155/2016/5234969. Epub 2016 Mar 10. Can J Gastroenterol Hepatol. 2016. PMID: 27446846 Free PMC article. Review.
-
Predictors of treatment response in chronic hepatitis B.Drugs. 2009 Nov 12;69(16):2167-77. doi: 10.2165/11319850-000000000-00000. Drugs. 2009. PMID: 19852523 Review.
-
Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase.Virus Genes. 2010 Apr;40(2):174-82. doi: 10.1007/s11262-009-0441-3. Epub 2010 Jan 28. Virus Genes. 2010. PMID: 20107884
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical